These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35786827)

  • 1. Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy.
    Chen X; Jia F; Huang Y; Jin Q; Ji J
    ACS Appl Bio Mater; 2022 Jul; 5(7):3544-3553. PubMed ID: 35786827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Yu R; Zhao C; Liang J; Zhang Y; Su H; Zhao J; Wu H; Xu S; Zhang Z; Wang L; Zou X; Zhu Y; Zhang S; Lv Y
    Adv Sci (Weinh); 2024 Jan; 11(1):e2305279. PubMed ID: 37968249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy.
    Zhao X; Yang X; Wang X; Zhao X; Zhang Y; Liu S; Anderson GJ; Kim SJ; Li Y; Nie G
    ACS Nano; 2021 Sep; 15(9):14149-14161. PubMed ID: 34478262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer.
    Ji T; Li S; Zhang Y; Lang J; Ding Y; Zhao X; Zhao R; Li Y; Shi J; Hao J; Zhao Y; Nie G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):3438-45. PubMed ID: 26759926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment.
    Chen X; Jia F; Li Y; Deng Y; Huang Y; Liu W; Jin Q; Ji J
    Biomaterials; 2020 Jul; 246():119999. PubMed ID: 32247201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer.
    Zhou Y; Ma Y; Sheng J; Ma Y; Ding J; Zhou W
    Mol Pharm; 2024 Aug; 21(8):3764-3776. PubMed ID: 39049481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy.
    Ji T; Lang J; Wang J; Cai R; Zhang Y; Qi F; Zhang L; Zhao X; Wu W; Hao J; Qin Z; Zhao Y; Nie G
    ACS Nano; 2017 Sep; 11(9):8668-8678. PubMed ID: 28806504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer.
    Feng J; Xu M; Wang J; Zhou S; Liu Y; Liu S; Huang Y; Chen Y; Chen L; Song Q; Gong J; Lu H; Gao X; Chen J
    Biomaterials; 2020 May; 241():119907. PubMed ID: 32120315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.
    Xue X; Wang X; Pang M; Yu L; Qian J; Li X; Tian M; Lu C; Xiao C; Liu Y
    J Nanobiotechnology; 2024 Apr; 22(1):196. PubMed ID: 38644492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking the stromal barrier in pancreatic cancer: Advances and challenges.
    Chakkera M; Foote JB; Farran B; Nagaraju GP
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189065. PubMed ID: 38160899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
    Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
    Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem.
    Zhou X; Zhang P; Liu N; Zhang X; Lv H; Xu W; Huo M
    J Control Release; 2023 Sep; 361():161-177. PubMed ID: 37536546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
    Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
    J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic Polymer-Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response.
    Zhang Y; Fang Z; Pan D; Li Y; Zhou J; Chen H; Li Z; Zhu M; Li C; Qin L; Ren X; Gong Q; Luo K
    Adv Mater; 2024 Jun; 36(25):e2401304. PubMed ID: 38469918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.
    Li Y; Zhao Z; Liu H; Fetse JP; Jain A; Lin CY; Cheng K
    ACS Appl Mater Interfaces; 2019 Dec; 11(49):45390-45403. PubMed ID: 31769963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.